万泰生物 (603392)

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

ASH

Tags

300 Non-Cyclical IndexDeepSeekMSCI Component StocksSSE 180 IndexSSE Mid Cap IndexCSI 200 IndexInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareHelicobacter PyloriPrivate Enterprises 100 IndexCSI 300 IndexConsumption 100 IndexBiological ProductsBiological VaccinesMargin Trading and Securities LendingNon-Cyclical Stocks医药生物

K-Line Chart

No K-line data available

Company NameBeijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Listing Date2020-04-29
Issue Price8.75RMB
Registered Capital126439.280410k RMB
Legal RepresentativeQiu Zixin
Registered AddressNo. 31 Kexueyuan Road, Changping District, Beijing
IndustryBiological Products
Main BusinessResearch, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines.
Company ProfileWantai Biological Pharmacy Enterprise Co., Ltd. is a subsidiary of Yangshengtang Co., Ltd. It is a high-tech enterprise engaged in the research, development, and production of biological diagnostic reagents and vaccines. Guided by the philosophy of 'Science-based, Health-focused', the mission of 'Survival through Quality, Development through Technological Innovation', and the pursuit of 'Contributing to Human Health', the company transforms biotechnology achievements into high-quality products to serve the public. The company was founded in 1991. After 20 years of development and accumulation, it has grown from a small-scale laboratory at its inception to a modern diagnostic reagent production base covering an area of 35,000 square meters with a building area of 20,000 square meters. The company has over 800 employees and has become a major HIV diagnostic reagent production base in the Asia-Pacific region, a well-known Chinese immunodiagnostic reagent manufacturer, and a national high-tech biotechnology industrialization demonstration project base.

Stock Details

1. Key Indicators

  • Total Shares(W): 126512.28
  • Circulating A-Shares(W): 126512.28
  • Earnings Per Share(RMB): -0.1400
  • Net Assets Per Share(RMB): 9.5560
  • Operating Revenue(W RMB): 149836.99
  • Total Profit(W RMB): -19185.64
  • **Net Profit Attributable to Parent(W RMB) **: -17342.20
  • Net Profit Growth Rate(%): -165.04
  • Weighted Return on Equity(%): -1.4200
  • Operating Cash Flow Per Share(RMB): 0.0060
  • Undistributed Profit Per Share(RMB): 5.5793
  • Capital Reserve Per Share(RMB): 2.4816

2. Main Business

The main business covers:

  • Research, development, production and sales of in vitro diagnostic reagents
  • Research, development, production and sales of instruments
  • Research, development, production and sales of vaccines

3. Company Basic Information

  • Company Name: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Listing Date: 2020-04-29
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 31 Kexueyuan Road, Changping District, Beijing
  • Website: https://www.ystwt.com
  • Company Profile: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. was established with Beijing Capital Venture Group as the main sponsor. Based on the audited net assets of 111.5008 million yuan as of October 31, 2007, it was converted into 55 million shares of the company's stock, with the remainder included in the company's capital reserve. The company is mainly engaged in the research, development, production and sales of in vitro diagnostic reagents, instruments and vaccines.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yangshengtang Co., Ltd. General Legal Person 70580.79 55.79
2 Hong Kong Securities Clearing Company Limited Northbound Capital 1289.91 1.02
3 Huatai-Pinebridge CSI 300 ETF Fund 640.61 0.51
4 China Merchants China Securities Biomedical Index Fund (LOF) Class A Fund 496.09 0.39
5 Harvest China Securities Vaccine and Biotechnology ETF Fund 31.94 0.03
6 ChinaAMC China Securities Vaccine and Biotech Index Fund Class A Fund 15.89 0.01
7 Penghua China Securities Vaccine and Biotech ETF Fund 12.50 0.01
8 Guotai China Securities Vaccine and Biotech ETF Fund 5.62 0.00
9 Yimi Kaitai Mixed Securities Investment Fund Class A Fund 3.56 0.00
10 China Merchants China Securities Vaccine and Biotechnology ETF Fund 2.82 0.00

5. Concept Sectors

  • Biological Vaccines
  • Helicobacter Pylori
  • Innovative Drugs
  • DeepSeek

Remarks

  • Data update date: 2025-11-02
  • Data source: Public Market Information